Our Approach to Innovation
 

Our Mission is to Simplify Life for People with Diabetes and to Simplify Diabetes Care

With Omnipod® 5 we created the first and only tubeless Automated Insulin Delivery (AID) system in the US, but we’re not stopping there. We’re continuing to lead the tubeless pump revolution by diligently working on offering our consumers a choice of phone operating system for the Omnipod 5 App and also sensor of choice among the biggest sensors available on the market.

What's New

Omnipod 5 App for iPhone

Omnipod 5 App for iPhone with Dexcom G7 is available! Now our patients can enjoy the freedom and convenience of controlling the Pod from a compatible iPhone or Android smartphone without the need to carry the Controller.2 For any questions, read our FAQs here.

Omnipod Discover™ in Limited Market Release

Omnipod Discover, Insulet's proprietary diabetes data insights system, empowers healthcare providers and Omnipod users to collaborate on optimizing diabetes management.

Omnipod Discover on a laptop illustration Omnipod Discover on a laptop illustration

FDA Clearance of Omnipod 5 for Adults with Type 2 Diabetes

We have groundbreaking news that Omnipod 5 is now indicated for people with type 2 diabetes (ages 18 years and older) in the United States! This makes it the first and only automated insulin delivery system FDA-cleared for both type 1 and type 2 diabetes management. For any questions, read our FAQs here.

Omnipod 5 and Dexcom G7

We're excited to announce that Omnipod 5 integration with Dexcom G7 is now broadly available in retail pharmacies across the U.S.! This is another step toward our goal of offering Omnipod 5 users a choice of CGM sensor. For any questions, read our FAQs here.

Omnipod® 5 and FreeStyle Libre 2 Plus Sensor

The Omnipod® 5 System is now integrated with the FreeStyle Libre 2 Plus Sensor! With this new sensor integration, users will benefit from tubeless automated insulin delivery along with the convenience of a 15-day wear CGM sensor, and the ability to start, deactivate, and view sensor glucose data directly from the Omnipod 5 Controller. FAQs here

What's Next

Sensor Integration

We are proud to partner with Dexcom and Abbott to expand our Omnipod 5 sensor integration options, giving users choice in the device they use for glucose monitoring.

Frequently Asked Questions


Stay in the Know About Innovation and Other Omnipod News

“The Pod is a revolution in insulin therapy - No tubes, less needle sticks, constant insulin delivery for 3 days - no disconnect. All of these factors improve adherence among people with diabetes and, as a result, dramatically improve clinical outcomes and quality of life.”

Dr. Michael R. Brennan

D.O., M.S., F.A.C.E., F.A.C.P., is an award-winning endocrinology, diabetes and metabolism specialist and founder of the Beaumont Endocrine Center. Dr. Brennan has an ongoing commercial relationship with Insulet.

Get the Latest Updates

Healthcare Providers: Be the first to hear about updates from the Omnipod® Team.

A Look Behind the Scenes


Awards & Recognition

Our greatest reward is the impact our products have on the people who use them and their caregivers. We’re also pleased that our hard work and advanced approach have been recognized by industry organizations.

HCP with young podder patient and parent HCP with young podder patient and parent

2022

Omnipod 5 Voted #1 Favorite Pump in the US, Patient Choice Award Winner1

2021

Top Ten Wearable Medical Device Solution Provider, according to MD Tech Review

2020

Top Ten Wearable Medical Device Solution Provider, according to MD Tech Review

Omnipod DASH® System named the 2020 Product of the Year in the Health Systems Category by 40,000 U.S. Consumers

*The Omnipod brand was named 2022 Patient Choice Award Winner for preferred pump; Seagrove Patient Perspectives Survey Report (304 Total Responses, 229 T1D, 75 T2D - 203 pumpers, 64 MDI, 37 non-MDI). Seagrove Partners, LLC Patient Perspectives Report, December 2022. Insulet data on file.

1. The Omnipod brand was named 2022 Patient Choice Award Winner for preferred pump; Seagrove Patient Perspectives Survey Report (304 Total Responses, 229 T1D, 75 T2D - 203 pumpers, 64 MDI, 37 non-MDI). Seagrove Partners, LLC Patient Perspectives Report, December 2022. Insulet data on file.

2. For a list of compatible smartphone devices visit omnipod.com/compatibility